Daxor Corporation (DXR)

The momentum for this stock is not very good. Daxor Corporation (DXR) is a mediocre stock to choose.
Log in to see more information.
Daxor Corp. is a biotechnology company which develops and manufactures BVA-100 blood volume analyzer...
DXR Fundamental Data by TradingView

News

Daxor (NASDAQ:DXR) Price Target Raised to $24.75 at Ascendiant Capital Markets
Daxor (NASDAQ:DXR) Price Target Raised to $24.75 at Ascendiant Capital Markets

Ticker Report Daxor (NASDAQ:DXR - Free Report) had its price objective raised by Ascendiant Capital Markets from $24.50 to $24.75 in a research note published on Monday morning, Benzinga reports. The firm...\n more…

Daxor Corporation: A Buy Rating Justified by Strong Performance and Promising Medical Technology Outlook
Daxor Corporation: A Buy Rating Justified by Strong Performance and Promising Medical Technology Outlook

TipRanks Financial Blog In a report released yesterday, Anthony Vendetti from Maxim Group reiterated a Buy rating on Daxor (DXR - Research Report), with a price target of ...\n more…

Daxor Corporation Receives $300K Matching Fund Award From Launch Tennessee
Daxor Corporation Receives $300K Matching Fund Award From Launch Tennessee

Globe Newswire The SBIR Matching Fund Award Will Drive Our Innovation, Commercialization Efforts, and Job Creation Oak Ridge, TN, Sept. 05, 2024 (GLOBE NEWSWIRE) -- Daxor Corporation (NASDAQ: DXR), the global...\n more…

Leading Central Florida Hospital Implements Daxor's BVA-100 Blood Volume Diagnostic for Heart Failure Patient Care
Leading Central Florida Hospital Implements Daxor's BVA-100 Blood Volume Diagnostic for Heart Failure Patient Care

Globe Newswire 1,000 Bed Comprehensive Medical Center Launches ezBVA Lab Program Oak Ridge, TN, Sept. 04, 2024 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement...\n more…

Daxor CEO says NAV increased to $6.75 p/s from $6.33 last year this time
Daxor CEO says NAV increased to $6.75 p/s from $6.33 last year this time

The Fly See the rest of the story here.\n\nthefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...\n more…

Daxor Corporation CEO and President Michael Feldschuh Delivers Corporate Update in Shareholder Letter
Daxor Corporation CEO and President Michael Feldschuh Delivers Corporate Update in Shareholder Letter

Globe Newswire Oak Ridge, TN, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, today provides a mid-year corporate and financial update...\n more…